Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-03-04
2008-03-04
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S014800, C536S001110, C536S018700, C536S022100
Reexamination Certificate
active
10292896
ABSTRACT:
Attachment of O-glycans to proteins is controlled by a large family of homologous polypeptide GalNAc-transferases. Polypeptide GalNAc-transferases contain a C-terminal sequence with similarity to lectins. This invention discloses that the putative lectin domains of GalNAc-transferase isoforms, GalNAc-T4, -T7, -T2, and -T3, are functional and recognize carbohydrates, glycopeptides, and peptides and discloses the lectin domains of GalNAc-T1-T16. These lectin domains have different binding specificities and modulate the functions of GalNAc-transferase isoforms differently. Novel methods for identification of inhibitors or modulators of binding activities mediated by lectin domains of polypeptide GalNAc-transferases are disclosed. Direct binding activity of GalNAc-transferase lectins has been demonstrated for the first time and methods to measure lectin mediated binding of isolated lectins or enzymes with lectin domains are disclosed. The present invention specifically discloses a novel selective inhibitor of polypeptide GalNAc-transferase lectin domains, which provides a major advancement in that this inhibitor and related inhibitors sharing common characteristics of activity bind lectin domains without serving as acceptor substrate for glycosyltransferases involved in synthesis of O-glycans. This inhibitor is represented by the β-anomeric configuration of GalNAc-benzyl, GalNAcβ-benzyl. Methods for inhibiting intracellular transport, cell surface expression, and secretion of mucins and O-glycosylated glycoproteins without affecting O-glycosylation processing are disclosed using the novel selective inhibitor identified.
REFERENCES:
patent: 5268364 (1993-12-01), Kojima et al.
patent: WO-99/12944 (1999-03-01), None
patent: WO-99/64378 (1999-12-01), None
patent: WO-01/85215 (2001-11-01), None
Chung et al., “Acceptor Substrate-Based Selective Inhibition of Galactosyltransferases”, Bioorganic & Medicinal Chemistry Letters, 8 (1998) 3359-3364.
M. Tenno et al., Identification of two cysteine residues involved in the binding of UDP-GalNAc to UDP-CalNAc: polypeptide N-acetylgalactosaminyltransferase 1 (GalNAc-T1), European Journal of Biochemistry, Sep. 2002, vol. 269, No. 17, Abstract.
International Search Report, dated Feb. 15, 2002, which issued during the prosecution of International Application No. PCT/DK01/00328.
International Search Report, dated Jul. 26, 2004, which issued during the prosecution of International Application No. PCT/DK03/00763.
Abstract. Publication No. WO-95/26969 A1, New Derivative Inhibit Cell Adhesive Galactosyl Fucosyl Group Treat Inflammation Asthma Rheumatism Cancer.
Soudan, et al., “Capillary zone electrophoresis and MALDI-mass spectrometry for the monitoring of in vitro O-glycosylation of a threonine/serine-rich MUC5AC hexdecapeptide”, Journal of Chromatography B, 1999, vol. 729, pp. 65-74.
Byrd, J.C., et al., “Inhibition of Mucin Synthesis by Benzyl-α-GalNAc in KATO III Gastric Cancer and Caco-2 Colon Cancer Cells”, European Journal of Cancer, 1995, vol. 31A, No. 9, pp. 1498-1505.
Homa, Fred L., et al., “Isolation and Expression of a cDNA Clone Encoding a Bovine UDP-GalNAc: Polypeptide N-Acetylgalactosaminyltransferase”, The Journal of Biological Chemistry, Jun. 15, 1993, vol. 268, No. 17, pp. 12609-12616.
Toba, Shinya, et al., “Brain-specific expression of a novel human UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase (GalNAc-T9)1”, Biochimica et Biophysica Acta, 2000, vol. 1493, pp. 264-268.
White, Kenneth E., et al., “Molecular cloning of a novel human UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase, GalNAc-T8, and analysis as a candidate autosomal dominant hypophosphatemic rickets (ADHR) gene”, Gene, 2000, vol. 246, pp. 347-356.
Bennett, Eric Paul, et al., “Cloning and Characterization of a Close Homologue of Human UDP-N-acetyl-α-D-galactosamine:Polypeptide N-Acetylgalactosaminyltransferase-T3, Designated GalNAc-T6”, The Journal of Biological Chemistry, Sep. 3, 1999, vol. 274, No. 36, pp. 25362-25370.
Muller, Stefan, et al., “Recombinant MUC1 Probe Authentically Reflects Cell-specific O-Glycosylation Profiles of Endogenous Breast Cancer Mucin”, The Journal of Biological Chemistry, Jul. 19, 2002, vol. 277, No. 29, pp. 26103-26112.
Gouyer, V., et al., “Inhibition of the Glycosylation and Alteration in the Intracellular Trafficking of Mucins and Other Glycoproteins by GalNAca-O-BN in Mucosal Cell Lines: An Effect Medicated Through the Intracellular Synthesis of Complex GalNAca-O-BN Oligosaccharides”, Frontiers in Bioscience, Oct. 1, 2001, vol. 6, pp. d1235-d1244.
Tenno, Marl, et al., “The Lectin Domain of UDP-GalNAc:Polypeptide N-Acetylgalactosaminytransferase 1 is Involved in O-Gylcosylation of a Polypeptide with Multiple Acceptor Sites”, The Journal of Biological Chemistry, Dec. 6, 2002, vol. 277, No. 49, pp. 47088-47096.
Hagen, Kelly G. Ten, et al., “Cloning and Characterization of Ninth Member of the UDP-GalNAc:Polypeptide N-Acetylgalactosaminyltransferase Family, ppGaNTase-T9”, The Journal of Biological Chemistry, May 18, 2001, vol. 276, No. 20, pp. 17395-17404.
Schwientek, Tilo, et al., “Functional Conservation of Subfamilies of Putative UDP-N-acetylgalactosamine:Polypeptide N-Acetylgalactosaminyltransferases in Drosophila,Caaenorhabditis elegans, and Mammals”, The Journal of Biological Chemistry, Jun. 21, 2002, vol. 277, No. 25, pp. 22623-22638.
Hassan, Helle, et al., “The Lectin Domain of UDP-N-acetyl-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase-T4 Directs Its Glycopeptide Specificities”, The Journal of Biological Chemistry, Dec. 8, 2000, vol. 275, No. 49, pp. 38197-38205.
Gobom, Johan, et al., “Sample Purification and Preparation Technique Based on Nano-scale Reversed-Phase Columns for the Sensitive Analysis of Complex Peptide Mixtures by Matrix-assisted Laser Desorption/Ionization Mass Spectrometry”, Journal of Mass Spectrometry, 1999, vol. 34, pp. 105-116.
Mirgorodskaya, Ekaterina, et al., “Partial Vapor-Phase Hydrolysis of Peptide Bonds: A Method for Mass Spectrometric Determination of O-Glycosylated Sites in Glycopeptides”, Analytical Biochemistry, 1999, vol. 269, pp. 54-65.
Birken, Steven, et al., “Isolation and Amino Acid Sequence of COOH-terminal Fragments from the B Subunit of Human Choriogonadotropin”, The Journal of Biological Chemistry, Aug. 10, 1977, vol. 252, No. 15, pp. 5386-5392.
Hill, Hoyle D., Jr., et al., “Ovine Submaxillary Mucin”, The Journal of Biological Chemistry, Jun. 10, 1977, vol. 252, No. 11, pp. 3799-3804.
Hardy, Daniel M., et al., “A Sperm Membrane Protein that Binds in a Species-specific Manner to the Egg Extracellular Matrix is Homologous to von Willebrand Factor”, The Journal of Biological Chemistry, Nov. 3, 1995, vol. 270, No. 44, pp. 26025-26028.
Matsuura, Hidemitsu, et al., “An a-N-Acetylgalactosaminylation at the Threonine Residue of a Defined Peptide Sequence Creates the Oncofectal Peptide Epitope in Human Fibronectin”, The Journal of Biological Chemistry, Jun. 25, 1989, vol. 264, No. 18, pp. 10472-10476.
Bobek, Libuse A., et al., “Molecular Cloning, Sequence, and Specificity of Expression of the Gene Encoding the Low Molecular Weight Human Salivary Mucin (MUC7)”, The Journal of Biological Chemistry, Sep. 25, 1993, vol. 268, No. 27, pp. 20563-20569.
Gum, James R., Jr., et al., “Molecular Cloning of Human Intestinal Mucin (MUC2) cDNA”, The Journal of Biological Chemistry, Jan. 28, 1994, vo. 269, No. 4, pp. 2440-2446.
Albone, Earl F., et al., “Molecular Cloning of a Rat Submandibular Gland Apomucin”, The Journal of Biological Chemistry, Jun. 17, 1994, vol. 269, No. 24, pp. 16845-16852.
Day, Philip J., et al., “Structure and Activity of an Active Site Substitution of Ricin A Chain”, Biochemistry, 1996, vol. 35, pp. 11098-11103.
Wandal
Bennett Eric Paul
Clausen Henrik
Hassan Helle
Reis Celso Albuquerque
Darby & Darby
Glycozym APS
Ward Paul V.
Wilson James O.
LandOfFree
Methods of modulating functions of polypeptide... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of modulating functions of polypeptide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of modulating functions of polypeptide... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3953745